Data / Drug companies / Amphastar Nanjing Pharmaceuticals, Inc.
Amphastar Nanjing Pharmaceuticals, Inc.: 25 products in the FDA NDC directory, labeler code 52221
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amphastar Nanjing Pharmaceuticals, Inc. (labeler code 52221) lists 25 products in the FDA National Drug Code Directory. By type: 25 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 19, 2022.
The request: Watch Amphastar Nanjing Pharmaceuticals, Inc. (FDA labeler code 52221): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52221
- Products in commercial distribution
- 25
- Packages
- 27
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 12, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 20 | 80% |
| Powder, for suspension | 3 | 12% |
| Oil | 1 | 4% |
| Injection, powder, for suspension | 1 | 4% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Insulin degludec | 52221-127 | Powder | Bulk ingredients | October 19, 2022 |
| Insulin glargine | 52221-125 | Powder | Bulk ingredients | August 26, 2020 |
| Phytonadione | 52221-124 | Oil | Bulk ingredients | July 25, 2019 |
| Heparin sodium | 52221-123 | Powder | Bulk ingredients | December 4, 2018 |
| Epinephrine | 52221-114 | Powder | Bulk ingredients | July 25, 2018 |
| Sodium taurocholate hydrate | 52221-121 | Powder | Bulk ingredients | June 7, 2017 |
| Sodium taurocholate | 52221-120 | Powder | Bulk ingredients | June 7, 2017 |
| Teriparatide | 52221-119 | Powder | Bulk ingredients | June 7, 2017 |
| Medroxyprogesterone acetate | 52221-118 | Powder | Bulk ingredients | October 24, 2016 |
| Budesonide | 52221-117 | Powder | Bulk ingredients | December 22, 2015 |
| Formoterol fumarate | 52221-116 | Powder | Bulk ingredients | October 30, 2015 |
| Formoterol fumarate | 52221-116 | Powder | Bulk ingredients | October 30, 2015 |
| Insulin aspart | 52221-115 | Powder | Bulk ingredients | August 25, 2015 |
| Sodium nitroprusside | 52221-111 | Powder | Bulk ingredients | July 27, 2015 |
| Protamine sulfate | 52221-110 | Powder | Bulk ingredients | July 10, 2015 |
| Hyaluronidase | 52221-201 | Powder | Bulk ingredients | June 17, 2015 |
| Isoproterenol hydrochloride | 52221-112 | Powder | Bulk ingredients | June 2, 2015 |
| Salmeterol xinafoate | 52221-109 | Powder | Bulk ingredients | September 29, 2014 |
| Ipratropium bromide | 52221-108 | Powder | Bulk ingredients | July 21, 2014 |
| Atropine sulfate | 52221-107 | Powder | Bulk ingredients | July 21, 2014 |
| Idraparinux sodium | 52221-103 | Powder, for suspension | Bulk ingredients | June 1, 2014 |
| Fluticasone propionate | 52221-106 | Injection, powder, for suspension | Bulk ingredients | December 1, 2013 |
| Beclomethasone dipropionate | 52221-105 | Powder, for suspension | Bulk ingredients | December 1, 2013 |
| Huperzine a | 52221-104 | Powder, for suspension | Bulk ingredients | December 1, 2013 |
| Heparin sodium | 52221-101 | Powder | Bulk ingredients | April 12, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.